Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/Erapin Plus

Approved

STANDARD

Erapin Plus

Azarias Pharmaceutical Laboratories Inc.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 5e0c843a96530dc5
Company: Azarias Pharmaceutical Laboratories Inc.
Type: Standard

Approval Details

Approval Id: 5e0c843a96530dc5
Drug Approval Philippines Name: Erapin Plus
Product Name: Erapin Plus
Registration Number: DRP-12791-02
Brand Name: Erapin Plus
Generic Name: Amlodipine (as Besilate) + Hydrochlorothiazide
Dosage Form: Tablet
Dosage Strength: 10 mg / 12.5 mg
Manufacturer: Azarias Pharmaceutical Laboratories Inc.
Distributor: Errapel Pharmed Corp.
Issuance Date: 26 April 2024
Expiry Date: 28 October 2027
Pharmacologic Category: Calcium Channel Blocker and Diuretic
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

5e0c843a96530dc5

Type

Standard

Back to Philippines FDA Approvals

Erapin Plus - Philippines FDA Drug Approval Details